Your browser doesn't support javascript.
loading
Efficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis.
Tai, Felicia; Mehraban Far, Parsa; Pechlivanoglou, Petros; Ramsay, Lauren C; Georgakopoulos, Jorge R; Sander, Beate; Derzko-Dzulynsky, Larissa A; Felfeli, Tina.
Afiliação
  • Tai F; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Mehraban Far P; Department of Ophthalmology, Kingston Health Sciences Center, Queen's University, Kingston, Canada.
  • Pechlivanoglou P; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
  • Ramsay LC; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
  • Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.
  • Sander B; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Public Health Ontario, Toronto, Canada; ICES, Toronto, Canada.
  • Derzko-Dzulynsky LA; Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada; Department of Ophthalmology, St. Joseph's Health Centre, Unity Health Toronto, Toronto, Canada; Department of Ophthalmology, St. Michael's Hospital, Unity Health Toronto, Toronto, Canada.
  • Felfeli T; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada
Ophthalmology ; 129(3): 357-359, 2022 03.
Article em En | MEDLINE | ID: mdl-34634363

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uveíte / Adalimumab / Infliximab / Inibidores do Fator de Necrose Tumoral Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uveíte / Adalimumab / Infliximab / Inibidores do Fator de Necrose Tumoral Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article